Special Issue "Hormones and Carcinogenesis"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 31 July 2014
Prof. Dr. Robin Fuchs-Young
Department of Molecular and Cellular Medicine, College of Medicine and the Institute for Bioscience and Technology, 208 Reynolds Medical Building, Texas A&M Health Science Center College Station, TX 77843-1114, USA
Hormones play a critical role in cancer development in a variety of organs, including breast, uterus, ovary, prostate, testes, liver and others. Recent investigations have revealed that “cross-talk” between hormone and growth factor signaling networks affect the acquisition of the malignant phenotype, often in a tissue specific fashion. Environmental factors acting as hormonal mimics (endocrine disruptors) can alter both genetic integrity and epigenetic programs, and these effects can be further modulated by exposures during specific developmental periods (“windows of susceptibility”). This special issue of Hormones and Carcinogenesis is intended to incorporate a range of topics related to the contributions of steroid and peptide hormones to susceptibility, incidence, progression and treatment of cancer. We invite authors to submit primary papers as well as thoughtful reviews that elucidate mechanisms and pathways of hormonal carcinogenesis and/or that introduce new hypotheses and paradigms.
Prof. Dr Robin Fuchs-Young
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed Open Access quarterly journal published by MDPI.
- signaling/signal transduction
- cross talk
- endocrine disruptors
Review: Endometrial Serous Carcinoma: Its Molecular Characteristics and Histology-Specific Treatment Strategies
Cancers 2012, 4(3), 799-807; doi:10.3390/cancers4030799
Received: 4 June 2012; in revised form: 28 July 2012 / Accepted: 1 August 2012 / Published: 7 August 2012| Download PDF Full-text (933 KB) | View HTML Full-text | Download XML Full-text
Cancers 2012, 4(4), 969-988; doi:10.3390/cancers4040969
Received: 4 July 2012; in revised form: 9 August 2012 / Accepted: 10 September 2012 / Published: 25 September 2012| Download PDF Full-text (190 KB) | View HTML Full-text | Download XML Full-text
Last update: 25 February 2014